Coronavirus Researchers Codexery

Li Lanjuan

Chinese epidemiologist and developer of the Li-NBAL system.

Last updated

Li Lanjuan, born 13 September 1947, is a Chinese epidemiologist and hepatologist who serves as a professor at Zhejiang University School of Medicine and an academician of the Chinese Academy of Engineering. She directs the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and created the Li-NBAL artificial liver support system, a technology she shared freely with over 300 hospitals across China. Her leadership during the SARS, H1N1, and H7N9 outbreaks earned her multiple national science awards, including a special prize in 2017.

Early life and education

Li came from a poor peasant family in Shaoxing, Zhejiang, and was born on 13 September 1947. She performed well enough in school to gain admission to Hangzhou High School, a provincial key school. After finishing her studies, she worked as a substitute middle school teacher in her township.

She also learned acupuncture at Zhejiang Chinese Medicine Hospital and practiced on local elderly people. Her village recommended her for the role of barefoot doctor, which she took even though it paid less than teaching. In 1970, when universities started accepting Worker-Peasant-Soldier students, her township recommended her to study at Zhejiang Medical University, now part of Zhejiang University School of Medicine.

Career

After graduating in 1973, Li began working in the Department of Infectious Diseases at the First Affiliated Hospital of Zhejiang University. Because hepatitis B often caused acute liver failure in China, she and her team created an artificial liver support system (ALSS) in 1986, later called Li-NBAL, which cleans the blood of toxins and keeps patients alive until their liver regenerates or a transplant becomes available. This system raised survival rates for severe chronic hepatitis patients.

Rather than patenting it, she gave the technology to more than 300 hospitals across China at no cost. She served as Vice President of the First Affiliated Hospital from October 1993 for three years, then became deputy director of the State Key Laboratory of Infectious Diseases in November 1996, rising to director six years later. From 1998 to 2008, she held the position of Director of the Department of Health for the Zhejiang Provincial Government.

During the 2003 SARS outbreak, she led Zhejiang's disease prevention efforts and stopped the disease from spreading in the province. In 2013, when avian flu hit the Yangtze Delta, her team isolated the H7N9 strain and showed it came from live poultry markets. That finding led the government to shut down those markets, stopping the outbreak from reaching the rest of China. For this work, she received a special prize of the State Science and Technology Progress Award in 2017.

During the COVID-19 pandemic, she was among the researchers who suggested locking down Wuhan, a proposal the Chinese government adopted, implementing the lockdown at 2pm on 23 January 2020. On 1 February 2020, she traveled to Wuhan with a medical team from Hangzhou to fight the epidemic. On 20 April 2020, Stephen Chen of the South China Morning Post reported that Li's team at Zhejiang University had identified over 30 strains of SARS-CoV-2, with some aggressive strains generating 270 times more viral load than the mildest ones.

They linked the aggressive strains to outbreaks in Europe and New York State, while milder strains appeared in Washington and California.

More in Coronavirus Researchers

Sources

Compiled from Wikipedia and the sources listed below. Text from Wikipedia is available under CC BY-SA 4.0; this entry is adapted from it.

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →